谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

A phase 3, randomized, double-blind, adaptive, placebo/paclitaxel-controlled study of AVB-S6-500 in combination with paclitaxel in patients with platinum-resistant recurrent ovarian cancer (GOG-3059/ENGOT OV-66/AVB500-OC-004).

Katherine Cynthia Fuh,Thomas J. Herzog,Kathleen N. Moore,Tashanna K. N. Myers,B. J. Rimel,Joyce F. Liu,Angeles Alvarez Secord,Erika P. Hamilton,Thomas J. Reid,Sharyn Nan Lewin,Mary M. Mullen,Kathryn A. Mills,Randy Anderson,Reshma A. Rangwala

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 0|浏览22
暂无评分
关键词
ovarian cancer,double-blind,paclitaxel-controlled,platinum-resistant
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要